Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway.